Healthpeak Properties, Inc.DOCNYSE

Overview Intelligence Charts News Fundamentals DCF Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 53% recommend buying.

Consensus Rating

Buy

30 analysts·High coverage

53%

Rating Distribution

Strong Buy

00%

Buy

1653%

Hold

1447%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 8% higher.

Bear Case

$17.00

-2%

Consensus

$18.71

+8%

Bull Case

$21.00

+22%

Price Range30 analysts

Low

Consensus

High

$17.00

$21.00

Current Target

Current Price

$17.27

Upside to Target

$1.44

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$0.27(2 analysts)

P/E168x

Current: 168.0x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+3.78%

EPS+10.47%

FY2028

Rev+7.95%

EPS+4.00%

Earnings Surprises

Beat rate:75%(9/12 quarters)

Avg surprise:+70.0%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Feb 3, 2026Wells Fargo

Healthpeak Properties price target lowered to $18 from $19 at Wells Fargo

Target:$18.00

+6.4%from $16.92

Jan 9, 2026Goldman Sachs

Healthpeak Properties initiated with a Neutral at Goldman Sachs

Target:$17.00

-0.2%from $17.04

Jan 5, 2026Cantor Fitzgerald

Healthpeak Properties price target lowered to $17 from $20 at Cantor Fitzgerald

Target:$17.00

+5.2%from $16.16

Dec 15, 2025Jefferies

Healthpeak Properties downgraded to Hold from Buy at Jefferies

Target:$17.00

+2.0%from $16.66

Dec 15, 2025Evercore ISI

Healthpeak Properties price target lowered to $21 from $22 at Evercore ISI

Target:$21.00

+25.0%from $16.80

Oct 1, 2025Cantor Fitzgerald

Healthpeak Properties initiated with a Neutral at Cantor Fitzgerald

Target:$20.00

+4.4%from $19.15

Sep 15, 2025Evercore ISI

Healthpeak Properties price target lowered to $22 from $23 at Evercore ISI

Target:$22.00

+21.7%from $18.08

Sep 15, 2025Raymond James

Healthpeak upgraded to Outperform from Market Perform at Raymond James

Target:$20.00

+9.6%from $18.25

Aug 22, 2025Morgan Stanley

Healthpeak Properties price target lowered to $21 from $22 at Morgan Stanley

Target:$21.00

+18.3%from $17.75

Jul 30, 2025Robert W. Baird

Healthpeak Properties price target lowered to $21 from $22 at Baird

Target:$21.00

+22.0%from $17.22

Oct 21, 2024Deutsche Bank

Deutsche upgrades Healthpeak to Buy on improving life sciences sector

Target:$28.00

+23.7%from $22.64

Aug 21, 2024Citigroup

Healthpeak Properties price target raised to $22 from $20 at Citi

Target:$22.00

+0.5%from $21.89

Jul 30, 2024Robert W. Baird

Healthpeak Properties Inc (DOC) PT Raised to $24 at Baird

Target:$24.00

+9.8%from $21.85

Jul 30, 2024RBC Capital

Healthpeak Properties Inc (DOC) PT Raised to $25 at RBC Capital

Target:$25.00

+14.4%from $21.85

May 3, 2024Wedbush

Wedbush Upgrades Healthpeak Properties Inc (DOC) to Outperform

Target:$22.00

+14.8%from $19.17

Apr 10, 2024RBC Capital

Healthpeak Properties Inc (DOC) PT Raised to $22 at RBC Capital

Target:$22.00

+13.8%from $19.34

Mar 27, 2024Robert W. Baird

Healthpeak Properties Inc (DOC) PT Lowered to $22 at Baird

Target:$22.00

+20.2%from $18.31

Mar 25, 2024Wells Fargo

Wells Fargo Resumes Healthpeak Properties Inc (DOC) at Equal Weight

Target:$19.00

+8.3%from $17.54

Aug 1, 2023Credit Suisse

Check Out 3 Real Estate Stocks With Over 6% Dividend Yields From Wall Street's Most Accurate Analysts

Target:$15.00

+2.5%from $14.64

Aug 31, 2022Morgan Stanley

Morgan Stanley Maintains Equal-Weight on Physicians Realty Trust, Raises Price Target to $16.5

Target:$16.50

-2.7%from $16.95

Jul 15, 2022Morgan Stanley

Morgan Stanley Maintains Equal-Weight on Physicians Realty Trust, Lowers Price Target to $16

Target:$16.00

-4.5%from $16.76

Jul 11, 2022Truist Financial

Truist Securities Maintains Hold on Physicians Realty Trust, Lowers Price Target to $17

Target:$17.00

+2.5%from $16.58

Jun 30, 2022Jefferies

Jefferies Maintains Buy on Physicians Realty Trust, Lowers Price Target to $20

Target:$20.00

+13.8%from $17.58

Jun 1, 2022Morgan Stanley

Morgan Stanley Maintains Equal-Weight on Physicians Realty Trust, Lowers Price Target to $17.5

Target:$17.50

-5.7%from $18.55

Apr 26, 2022Barclays

Barclays Initiates Coverage On Physicians Realty Trust with Overweight Rating, Announces Price Target of $20

Target:$20.00

+13.8%from $17.58

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance